Article

Evidence-Based Interventions for Cancer- and Treatment-Related Cognitive Impairment

Diane Von Ah

Catherine E. Jansen

Deborah "Hutch" Allen
cognitive impairment, intervention, evidence-based practice
CJON 2014, 18(6), 17-25. DOI: 10.1188/14.CJON.S3.17-25

Cancer- and cancer treatment-related cognitive impairment is a common, bothersome, and potentially debilitating symptom incurred by cancer survivors. Cognitive impairment has a significant impact on patients' day-to-day functioning and quality of life, but it remains under-recognized and undertreated. This article, which is an update from the initial Oncology Nursing Society Putting Evidence Into Practice for cancer- and cancer treatment-related cognitive impairment, provides a comprehensive critical review and summary of the evidence regarding interventions addressing cognitive impairment for cancer survivors. This article examines the effectiveness of interventions focused on cancer- and cancer treatment-related cognitive impairment, makes recommendations for practice, and identifies gaps in knowledge and areas for further research.

Jump to a section

    References

    Ahles, T. A., & Saykin, A. J. (2007). Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews. Cancer, 7, 192-201. doi:10.1038/nrc2073
    Alvarez, J., Meyer, F. L., Granoff, D. L., & Lundy, A. (2013). The effect of EEG biofeedback on reducing postcancer cognitive impairment. Integrative Cancer Therapies, 12, 475-487. doi:10.1177/1534735413477192
    American Society of Clinical Oncology. (2013). Attention, thinking, and memory problems. Retrieved from http://www.cancer.net/navigating-cancer-care/side-effects/attention-thinking-or-memory-problems
    Attia, A., Rapp, S. R., Case, L. D., D'Agostino, R., Lesser, G., Naughton, M., … Shaw, E. G. (2012). Phase II study of Gingko biloba in irridiated brain tumor patients: Effect on cognitive function, quality of life, and mood. Journal of Neuro-Oncology, 109, 357-363. doi:10.1007/s11060-012-0901-9
    Ball, K., Berch, D. B., Helmers, K. F., Jobe, J. B., Leveck, M. D., Marsiske, M., … Willis, S. L. (2002). Effects of cognitive training interventions with older adults: A randomized controlled trial. JAMA, 288, 2271-2281.
    Ball, K., Edwards, J. D., & Ross, L. A. (2007). The impact of speed of processing training on cognitive and everyday functions. Journals of Gerontology: SERIES B, Psychological Sciences and Social Sciences, 62(Special Issue 1), 19-31.
    Barton, D. L., Burger, K., Novonty, P. J., Fitch, T. R., Kohli, S., Soori, G., … Loprinzi, C. L. (2013). The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Supportive Care in Cancer, 21, 1185-1192. doi:10.1017.s00520-012-1647-9
    Baumann, F. T., Drosselmeyer, N., Leskaroski, A., Knicker, A., Krakowski-Roosen, H., Zopf, E. M., & Bloch, W. (2011). 12-week resistance training with breast cancer patients during chemotherapy: Effects on cognitive abilities. Breast Care, 6, 142-143. doi:10.1159/000327505
    Bender, C. M., & Thelen, B. D. (2013). Cancer and cognitive changes: The complexity of the problem. Seminars in Oncology Nursing, 29, 232-237. doi:10.1016/j.soncn.2013.08.003
    Bjelakovic, G., Nikolova, D., Gluud, L. L., Simonetti, R. G., & Gluud, C. (2007). Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: Systematic review and meta-analysis, JAMA, 297, 842-857. doi:10.1001/jama.297.8.842
    Blackhall, L., Petroni, G., Shu, J., Baum, L., & Farace, E. (2009). A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. Journal of Palliative Medicine, 12, 433-439. doi:10.1089/jpm.2008.0230
    Brown, P. D., Pugh, S., Laack, N. N., Wefel, J. S., Khuntia, D., Meyers, C., … Radiation Therapy Oncology Group. (2013). Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: A randomized, double-blind, placebo-controlled trial. Neuro-Oncology, 24, 1613-1622. doi:10.1093/neuroc/not114
    Bruera, E., Miller, M. J., Macmillan, K., & Kuehn, N. (1992). Neuropsychological effects of methylphenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain, 48(2), 163-166.
    Butler, J. M., Jr., Case, L. D., Atkins, J., Frizzell, B., Sanders, G., Griffin, P., … Shaw, E. G. (2007). A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threomethylphenidate HCl in brain tumor patients receiving radiation therapy. International Journal of Radiation Oncology, Biology, and Physics, 69, 1496-1501. doi:10.1016/j.ijrobp.2007.05.076
    Calvio, L., Peugeot, M., Bruns, G. L., Todd, B. L., & Feuerstein, M. (2010). Measures of cognitive function and work in occupationally active breast cancer survivors. Journal of Occupational and Environmental Medicine, 52, 219-227. doi:10.1097/JOM.0b013e3181d0bef7
    Centers for Disease Control and Prevention. (2011). Physical activity and health. Retrieved from http://www.cdc.gov/physicalactivity/everyone/health/index.html
    Chan, A. S., Cheung, M. C., Law, S. C., & Chan, J. H. (2004). Phase II study of alpha-tocopherol in improving the cognitive function of patients with temporal lobe radionecrosis. Cancer, 100, 398-404. doi:10.1002/cncr.11885
    Chang, J., Couture, F. A., Young, S. D., Lau, C. Y., & McWatters, K. L. (2004). Weekly administration of epoetin alfa improves cognition and quality of life in patients with breast cancer receiving chemotherapy. Supportive Cancer Therapy, 2, 52-58. doi:10.3816/SCT.2004.n.023
    Cherrier, M. M., Anderson, K., David, D., Higano, C. S., Gray, H., Church, A., & Willis, S. L. (2013). A randomized trial of cognitive rehabilitation in cancer survivors. Life Sciences, 93, 617-622. doi:10.1016/j.lfs.2013.08.011
    Cimprich, B. (1993). Development of an intervention to restore attention in cancer patients. Cancer Nursing, 16, 83-92.
    Cimprich, B., & Ronis, D. L. (2003). An environmental intervention to restore attention in women with newly diagnosed breast cancer. Cancer Nursing, 26, 284-292.
    Escalante, C. P., Meyers, C. A., Reuben, J. M., Wang, X., Qiao, W., Manzullo, E., … Cleeland, C. (2014). A randomized, double-blind, 2-period, placebo-controlled crossover trial of a sustained-release methylphenidate in the treatment of fatigue in cancer patients. Cancer Journal, 20(1), 8-14. doi:10.1097/PPO.0000000000000018
    Falleti, M. G., Sanfilippo, A., Maruff, P., Weih, L., & Phillips, K. A. (2005). The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: A meta-analysis of the current literature. Brain and Cognition, 59(1), 60-70. doi:10.1016/j.bandc.2005.05.001
    Ferguson, R. J., Ahles, T. A., Saykin, A. J., McDonald, B. C., Furstenberg, C. T., Cole, B. F., & Mott, L. A. (2007). Cognitive-behavioral management of chemotherapy-related cognitive change. Psycho-Oncology, 16, 772-777. doi:10.1002/pon.1133
    Ferguson, R. J., McDonald, B. C., Rocque, M. A., Furstenberg, C. T., Horrigan, S., Ahles, T. A., & Saykin, A. J. (2012). Development of CBT for chemotherapy-related cognitive change: Results of a waitlist control trial. Psycho-Oncology, 21, 176-186. doi:10.1002/pon.1878
    Feuerstein, M., Hansen, J. A., Calvio, L. C., Johnson, L., & Ronquillo, J. G. (2007). Work productivity in brain tumor survivors. Journal of Occupational and Environmental Medicine, 49, 803-811. doi:10.1097/JOM.0b013e318095a458
    Gagnon, B., Low, G., & Schreier, G. (2005). Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: A prospective clinical study. Journal of Psychiatry and Neuroscience, 30, 100-107.
    Gehring, K., Patwardhan, S. Y., Collins, R., Groves, M. D., Etzel, C. J., Meyers, C. A., & Wefel, J. S. (2012). A randomized trial on the efficacy of methylphenidate and modafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. Journal of Neuro-Oncology, 107, 165-174. doi:10.1007/s11060-011-0723-1
    Gehring, K., Sitskoorn, M. M., Gundy, C. M., Sikkes, S. A., Klein, M., Postma, T. J., … Aaronson, N. K. (2009). Cognitive rehabilitation in patients with gliomas: A randomized, controlled trial. Journal of Clinical Oncology, 27, 3712-3722. doi:10.1200/jco.2008.20.5765
    Goedendorp, M. M., Knoop, H., Gielissen, M. F., Verhagen, C., & Bleijenberg, G. (2014). The effects of cognitive behavorial therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance. Journal of Pain and Symptom Management, 47(1), 35-44. doi:10.1016/j.jpainsymman.2013.02.014
    Gong, S., Sheng, P., Jin, H., He, H., Qi, E., Chen, W., … Hou, L. (2014). Effect of methylphenidate in patients with cancer-related fatigue: A systematic review and meta-analysis. PLoS One, 9, e84391. doi:10.1371/journal.pone.0084391
    Hassler, M. R., Elandt, K., Preusser, M., Lehrner, J., Binder, P., Dieckmann, K., … Marosi, C. (2010). Neurocognitive training in patients with high-grade glioma: A pilot study. Journal of Neuro-Oncology, 97, 109-115. doi:10.1007/s11060-009-0006-2
    Hoffman, C. J., Ersser, S. J., Hopkinson, J. B., Nicholls, P. G., Harrington, J. E., & Thomas, P. W. (2012). Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: A randomized, controlled trial. Journal of Clinical Oncology, 30, 1335-1342. doi:10.1200/JCO.2010.34.0331
    Holohan, K., Von Ah, D., McDonald, B. C., & Saykin, A. (2013). Neuroimaging, cancer, and cognition: State of the knowledge. Seminars in Oncology Nursing, 29, 280-287. doi:10.1016/j.soncn.2013.08.008
    Iconomou, G., Koutras, A., Karaivazoglou, K., Kalliolas, G. D., Assimakopoulos, K., Argyriou, A. A., … Kalofonos, H. P. (2008). Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy. European Journal of Cancer Care, 17, 535-541. doi:10.1111/j.1365-2354.2007.00857.x
    Janelsins, M. C., Kohli, S., Mohile, S. G., Usuki, K., Ahles, T. A., & Morrow, G. R. (2011). An update on cancer- and chemotherapy-related cognitive dysfunction: Current status. Seminars in Oncology, 38, 431-438.
    Jansen, C. (2010). Cognitive changes. In J. Eggert (Ed.), Cancer basics (pp. 361-369). Pittsburgh, PA: Oncology Nursing Society.
    Jansen, C. E. (2013). Cognitive changes associated with cancer and cancer therapy: Patient assessment and education. Seminars in Oncology Nursing, 29, 270-279. doi:10.1016/j.soncn.2013.08.007
    Jansen, C. E., Miaskowski, C., Dodd, M., Dowling, G., & Kramer, J. (2005). A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer, 104, 2222-2233. doi:10.1002/cncr.21469
    Jatoi, A., Kahanic, S. P., Frytak, S., Schaefer, P., Foote, R. L., Sloan, J., & Petersen, R. C. (2005). Donepezil and vitamin E for preventing cognitive dysfunction in small cell lung cancer patients: Preliminary results and suggestions for future study designs. Supportive Care in Cancer, 13, 66-69. doi:10.1007/s00520-004-0696-0
    Kesler, S. R., Hadi Hosseini, S. M., Heckler, C., Janelsins, M., Palesh, O., Mustian, K., & Morrow, G. R. (2013). Cognitive training for improving executive function in chemotherapy-treated breast cancer survivors. Clinical Breast Cancer, 13, 299-306. doi:10.1016/j.clbc.2013.02.004
    Kohli, S., Fisher, S. G., Tra, Y., Adams, M. J., Mapstone, M. E., Wesnes, K. A., … Morrow, G. R. (2009). The effect of modafinil on cognitive function in breast cancer survivors. Cancer, 115, 2605-2616. doi:10.1002/cncr.24287
    Korstjens, I., Mesters, I., van der Peet, E., Gijsen, B., & van den Borne, B. (2006). Quality of life of cancer survivors after physical and psychosocial rehabilitation. European Journal of Cancer Prevention, 15, 541-547. doi:10.1097/01.cej.0000220625.77857.95
    Livestrong Foundation. (2014). We can help/finishing treatment: Cognitive changes after cancer treatment. Retrieved from http://www.livestrong.org/we-can-help/finishing-treatment/cognitive-changes-after-cancer-treatment
    LoBiondo-Wood, G., Brown, C. G., Knobf, M. T., Lyon, D. E., Mallory, G., Mitchell, S. A., … Fellman, B. (2014). Priorities for oncology nursing: The 2013 national survey. Oncology Nursing Forum, 41, 67-76. doi:10.1188/14.ONF.67-76.
    Locke, D. E., Cerhan, J. H., Wu, W., Malec, J. F., Clark, M. M., Rummans, T. A., & Brown, P. D. (2008). Cognitive rehabilitation and problem-solving to improve quality of life of patients with primary brain tumors: A pilot study. Journal of Supportive Oncology, 6(8), 383-391.
    Lower, E. E., Fleishman, S., Cooper, A., Zeldis, J., Faleck, H., Yu, Z., & Manning, D. (2009). Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: A randomized clinical trial. Journal of Pain and Symptom Management, 38, 650-662. doi:10.1016/j.jpainsymman.2009.03.011
    Lundorff, L. E., Jønsson, B. H., & Sjøgren, P. (2009). Modafinil for attentional and psychomotor dysfunction in advanced cancer: A double-blind, randomised, cross-over trial. Palliative Medicine, 23, 731-738. doi:10.1177/0269216309106871
    Mancuso, A., Migliorino, M., De Santis, S., Saponiero, A., & De Marinis, F. (2006). Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of Oncology, 17, 146-150. doi:10.1093/annonc/mdj038
    Mar Fan, H. G., Clemons, M., Xu, W., Chemerynsky, I., Breunis, H., Braganza, S., & Tannock, I. F. (2008). A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer. Supportive Care in Cancer, 16, 577-583. doi:10.1007/s00520-007-0341-9
    Mar Fan, H. G., Park, A., Xu, W., Yi, Q. L., Braganza, S., Chang, J., Couture, F., & Tannock, I. F. (2009). The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer. Psycho-Oncology, 18, 156-161. doi:10.1002/pon.1372
    Massa, E., Madeddu, C., Lusso, M. R., Gramignano, G., & Mantovani, G. (2006). Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy. Critical Reviews in Oncology and Hematology 57, 175-182. doi:10.1016/j.critrevonc.2005.06.001
    McDougall, G. J. (2001). Memory improvement program for elderly cancer survivors. Geriatric Nursing, 22(4), 185-190.
    McDougall, G. J., Becker, H., Acee, T. W., Vaughan, P. W., & Delville, C. L. (2011). Symptom management of affective and cognitive disturbance with a group of cancer survivors. Archives of Psychiatric Nursing, 25(1), 24-35. doi:10.1016/j.apnu.2010.05.004
    Mehnert, A., Scherwath, A., Schirmer, L., Schleimer, B., Petersen, C., Schulz-Kindermann, F., … Koch, U. (2007). The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue, and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Education and Counseling, 66, 108-118.
    Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998). Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. Journal of Clinical Oncology, 16, 2522-2527.
    Milbury, K., Chaoul, A., Biegler, K. A., Wangyal, T., Spelman, A., Meyers, C. A., … Cohan, L. (2013). Tibetan sound meditation for cognitive dysfunction: Results of a randomized controlled pilot trial. Psycho-Oncology, 22, 2354-2363. doi:10.1002/pon.3296
    Miller, E. R., III, Pastor-Barriuso, R., Dalal, D., Riemersma, R. A., Appel, L. J., & Guallar, E. (2005). Meta-analysis: High-dosage vitamin E supplementation may increase all-cause mortality. Annals of Internal Medicine, 142, 37-46.
    Miotto, E. C., Savage, C. R., Evans, J. J., Wilson, B. A., Martin, M. G., Balardin, J. B., … Amaro Junior, E. (2013). Semantic strategy training increases memory performance and brain activity in patents with prefrontal cortex lesions. Clinical Neurology and Neurosurgery, 115, 309-316. doi:doi:10.1016/j.clineuro2012.05.024
    Mitchell, S. A., & Friese, C. R. (2014). ONS PEP (Putting Evidence Into Practice) weight-of-evidence classification: Decision rules for summative evaluation of a body of evidence. Retrieved from https://www.ons.org/practice-resources/pep/evaluation-process
    Munir, F., Burrows, J., Yarker, J., Kalawsky, K., & Bains, M. (2010). Women's perceptions of chemotherapy-induced cognitive side affects on work ability: A focus group study. Journal of Clinical Nursing, 19, 1362-1370. doi:10.111/j.1365-2702.2009.03006.4
    Myers, J. S. (2013). Cancer- and chemotherapy-related cognitive changes: The patient experience. Seminars in Oncology Nursing, 29, 300-307. doi:10.1016/j.soncn.2013.08.010
    Nada, S. E., & Shah, Z. A. (2012). Preconditioning with Ginkgo biloba (EGb 761®) provides neuroptrotection through H01 and CRMP2. Neurobiology of Disease, 46, 180-189. doi:10.10014/j.nbd.2012.01.006
    Oh, B., Butow, P. N., Mullan, B. A., Clarke, S. J., Beale, P. J., Pavlakis, N., … Vardy, J. (2012). Effect of medical qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: A randomized controlled trial. Supportive Care in Cancer, 20, 1235-1242. doi:10.1007/s00520-011-1209-6
    Oncology Nursing Society. (2014). Putting Evidence Into Practice: Cognitive impairment. Retrieved from https://www.ons.org/practice-resources/pep/cognitive-impairment
    Orgogozo, J. M., Rigaud, A. S., Stöffler, A., Möbius, H. J., & Forette, F. (2002). Efficacy and safety of memantine in patients with mild to moderate vascular dementia: A randomized placebo-controlled trial (MMM 300). Stroke, 33, 1834-1839.
    O'Shaughnessy, J. A. (2002). Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy. Clinical Breast Cancer, 3(Suppl. 3), S116-S120.
    O'Shaughnessy, J. A., Vukelja, S. J., Holmes, F. A., Savin, M., Jones, M., Royall, D., … Von Hoff, D. (2005). Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy. Clinical Breast Cancer, 5, 439-446.
    Poppelreuter, M., Weis, J., & Bartsch, H. H. (2009). Effects of specific neuropsychological training programs for breast cancer patients after adjuvant chemotherapy. Journal of Psychosocial Oncology, 27, 274-296. doi:10.1080/07347330902776044
    Reid-Arndt, S. A., Matsuda, S., & Cox, C. R. (2012). Tai chi effects on neuropsychological, emotional, and physical functioning: A pilot study. Complementary Therapies in Clinical Practice, 18(1), 26-30. doi:10.1016/j.ctcp.2011.02.005
    Rottmann, N., Dalton, S. O., Bidstrup, P. E., Würtzen, H., Høybye, M. T., Ross, L., … Johansen, C. (2012). No improvement in distress and quality of life following psychosocial cancer rehabilitation Psycho-Oncology, 21, 505-514. doi:10.1002/pon.1924
    Schuurs, A., & Green, H. J. (2013). A feasibility study of group cognitive rehabilitation for cancer survivors: Enhancing cognitive function and quality of life. Psycho-Oncology, 22, 1043-1049. doi:10.1002/pon.3102
    Schwartz, A. L., Thompson, J. A., & Masood, N. (2002). Interferon-induced fatigue in patients with melanoma: A pilot study of exercise and methylphenidate. [Online exclusive]. Oncology Nursing Forum, 29, E85-E90. doi:10.1188/02.ONF.E85-E90
    Shaw, E. G., Rosdhal, R., D'Agostino, R. B., Jr., Lovato, J., Naughton, M. J., Robbins, M. E., & Rapp, S. R. (2006). Phase II study of donepezil in irradiated brain tumor patients: Effect on cognitive function, mood, and quality of life. Journal of Clinical Oncology, 24, 1415-1420. doi:10.1200/JCO.2005.03.3001
    Sherer, M., Meyers, C. A., & Bergloff, P. (1997). Efficacy of postacute brain injury rehabilitation for patients with primary malignant brain tumors. Cancer, 80, 250-257.
    Sitzer, D. I., Twamley, E. W., & Jeste, D. V. (2006). Cognitive training in Alzheimer's disease: A meta-analysis of the literature. Acta Psychiatrica Scandinavica, 114(2), 75-90. doi:10.1111/j.1600-0447.2006.00789.x
    Smith, J. V., & Luo, Y. (2004). Studies on molecular mechanisms of Ginkgo biloba extract. Applied Microbiology and Biotechnology, 64, 465-472. doi:10.1007/s00253-003-1527-9
    Stewart, A., Bielajew, C., Collins, B., Parkinson, M., & Tomiak, E. (2006). A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clinical Neuropsychologist, 20(1), 76-89. doi:10.1080/138540491005875
    Stone, P., & Minton, O. (2011). European Palliative Care Research collaborative pain guidelines. Central side-effects management: What is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? Palliative Medicine, 25, 431-441. doi:10.1177/0269216310380763
    U. S. Food and Drug Administration. (2011). FDA drug safety communication: Erythropoiesis-stimulating agents (ESAs): Procrit, Epogen and Aranesp. Retrieved from http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200297.htm
    Vardy, J., Wefel, J. S., Ahles, T. A., Tannock, I. F., & Schagen, S. B. (2008). Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Annals of Oncology, 19, 623-629. doi:10.1093/annonc/mdm500
    Von Ah, D., Carpenter, J. S., Saykin, A., Monahan, P. O., Wu, J., Yu, M., … Unverzagt, F. (2012). Advanced cognitive training for breast cancer survivors: A randomized controlled trial. Breast Cancer Research and Treatment, 135, 799-809. doi:10.1007s10549-012-2210-6
    Von Ah, D., Jansen, C., Allen, D. H., Schiavone, R. M., & Wulff, J. (2011). Putting Evidence Into Practice: Evidence-based interventions for cancer and cancer treatment-related cognitive impairment. Clinical Journal of Oncology Nursing, 15, 607-615. doi:10.1188/11.CJON.607-615
    Von Ah, D., Russell, K. M., Storniolo, A. M., & Carpenter, J. S. (2009). Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncology Nursing Forum, 36, 326-336. doi:10.1188/09.ONF.326-336
    Wilcock, G., Möbius, H. J., Stoffler, A., & MMM 500 Group. (2002). A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). International Clinical Psychopharmacology, 17, 297-305.
    Wolinsky, F. D., Unverzagt, F. W., Smith, D. M., Jones, R., Wright, E., & Tennstedt, S. L. (2006). The effects of the ACTIVE cognitive training trial on clinically relevant declines in health-related quality of life. Journal of Gerontology, SERIES B, Psychological Sciences and Social Sciences, 61, S281-S287.
    Wolinsky, F. D., Vander Weg, M. W., Howren, M. B., Jones, M. P., & Dotson, M. M. (2013). A randomized controlled trial of cognitive training using a visual speed of processing intervention in middle aged and older adults. PLoS One, 8, e61624. doi:10.1371/journal.pone.0061624
    Zucchella, C., Capone, A., Dodella, V., De Nunzio, A. M., Vecchione, C., Sandrini, G., … Bartolo, M. (2013). Cognitive rehabilitation for early post-surgery inpatients affected by primary brain tumor: A randomized, controlled trial. Journal of Neuro-Onocology, 114, 93-100. doi:10.1007/s 11060-013011530-z